Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
LUCA ACHIEVES TARGETED THROUGHPUT RATES AT CAMPO MORADO AND TAHUEHUTO MINES
-
Full Circle Lithium Provides Important Corporate Updates
-
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
-
Compass to Announce Fourth Quarter and Full-Year 2024 Results on February 18
-
Ceva-Waves Wi-Fi 6 IP Powers WUQI Microelectronics Wi-Fi/Bluetooth Combo Chip
-
Addressing the Decline in National Reading Scores: The Imperative Role of ReadWorks
-
AXA XL and the Royal Academy of Arts Announce the 2025 edition of the AXA Art Prize UK
-
ValOre Affiliate Hatchet Uranium Corp. Closes $1,500,000 Financing Related to Saskatchewan Uranium Properties Acquisitions
-
CD&R Appoints Sam Camens as Managing Director
-
McDermott Completes Offshore Project in East Malaysia Ahead of Schedule
-
Spire reports FY25 first quarter results
-
Timken Announces Planned Retirement of Christopher A. Coughlin, EVP & President, Industrial Motion
-
Sable Samples up to 2.6% Cu at its Core Mountain Property in British Columbia
-
Aleph celebrates its 20-year anniversary
-
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
-
Harley-Davidson Delivers Fourth Quarter and Full Year Financial Results and 2025 Outlook
-
Japanese Consumers Say Yes to Cultured Eel in Poll by Forsea
-
TrustRadius Releases Its Third Annual Review Quality Report: Building Buyer Trust
-
Ahmad Al Ramahi Appointed CEO to Lead Hybrid Solutions' Next Phase of Growth
-
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
-
Ascot Resources Provides Further Update on CEO Review
-
Alsco Uniforms Continues Aggressive Growth Plans. Announces Acquisition of MacIntosh Services
-
CRITEO REPORTS RECORD FOURTH QUARTER 2024 RESULTS
-
Stable Kernel Unveils Comprehensive Technology Solutions to Transform the Foodservice Industry
-
Bladex's Fourth Quarter 2024 Conference Call
-
BioXcel Therapeutics Provides Clinical and Business Update
-
CDW Reports Fourth Quarter and Full Year 2024 Earnings
-
Plug Launches Industry's First Spot Pricing for Green Hydrogen
-
Old Dominion Freight Line Reports Fourth Quarter 2024 Earnings Per Diluted Share of $1.23
-
EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints
-
Performance Food Group Company Reports Second-Quarter and First-Six Months Fiscal 2025 Results
-
Eptura Builds Momentum with Strategic Leadership Appointments, New Service Offerings, & Industry-First Innovations
-
Reynolds Consumer Products Reports Fourth Quarter and Full Year 2024 Financial Results; Provides 2025 Outlook
-
LiveWire Group, Inc. Reports 2024 Fourth Quarter and Full Year Financial Results
-
Plymouth Industrial REIT Executes Value-Add Initiatives in Recently Acquired Memphis Logistics Portfolio
-
Marengo Therapeutics Announces the Appointment of Elena Garralda, MD, PhD, to its Scientific Advisory Board
-
The Hackett Group® Recognizes Employ as a Top Performer in its Talent Acquisition Software Provider Matrix™ 2025
-
Yelp Releases 2024 Trust & Safety Report
-
Altair Announces Next-Level Enhancements Within Altair® HPCWorks® 2025
-
Ethical Web AI appoints Tom Symonds as the new Chief Executive Officer
-
NationsBenefits Completes Strategic Investment in CareCar to Improve Transportation Access for Health Plan Members
-
ReposiTrak & Upshop Eliminate Gaps in Traceability with an End-to-End Solution
-
Air Industries Group Announces the Pay Down of $1.0M of Subordinated Debt
-
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
-
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Checkmarx Launches Collaborative Checkmarx Zero Research Hub to Share Application Security and Software Supply Chain Threat Intelligence
-
Ricky Ramon Joins OXIO From Verizon as SVP of Customer Experience
-
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
-
Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity Investment
-
Montauk Brewing Partners with JetBlue
